ISRCTN98553245进行中（未招募）未知
Cerebrolysin REGistry Study in Stroke- a High-quality Observational Study of Comparative Effectiveness
EVER Neuro Pharma (Austria)0 个研究点目标入组 1,851 人开始时间: 2021年4月27日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 1,851
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Signed informed consent
- •2. Clinical diagnosis of acute ischemic stroke confirmed by imaging
- •3. Moderate to severe neurological deficits with NIH Stroke Scale (NIHSS) 8 to 15, both inclusive
- •4. No prior stroke
- •5. No prior disability
- •6. Patient's independence prior to stroke onset (pre-morbid mRS of 0 or 1)
- •7. Reasonable expectation of successful follow-up (max. 100 days)
排除标准
- •Does not meet inclusion criteria
研究者
相似试验
终止
不适用
Cerebrolysin REGistry Study in StrokeIschemic StrokeNCT02541227Ever Neuro Pharma GmbH1,823
进行中（未招募）
1 期
Cerebrolysin and Recovery after Stroke (CARS) - A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase II Clinical Study. - CERE-REHA-1EUCTR2007-000870-21-PLEVER Neuro Pharma GmbH236
尚未招募
2 期
Cerebrolysin After Reperfusion in Extended-window EndoVascular ThrombectomyAcute Ischemic StrokeNCT06339411Chang Gung Memorial Hospital100
招募中
1 期
Is Cerebrolysin efficient in neurorecovery after moderate-severe traumatic brain injury?Moderate-severe traumatic brain injuryMedDRA version: 26.1Level: LLTClassification code 10060690Term: Traumatic brain injurySystem Organ Class: 10022117 - Injury, poisoning and procedural complicationsEUCTR2022-003382-38-ROFSNANO05012022440
尚未招募
不适用
The significance of serum uric acid in acute stroke.CTRI/2021/08/035792DR SAKSHI